Developer docs
API playgroundTry for free, no card

Search company profiles

MediZap

Full company profile

uuid0007tx4

Namestring
MediZap
Legal namestring
Medizap LLC
Websiteurl
medizap.co
Company typeenum
Private
Founded yearint
2018
Descriptiontext

MediZap is a private U.S. service provider that delivers E-Beam (electron beam) and X-Ray terminal sterilization for compounded pharmaceuticals, targeting 503A compounding pharmacies, 503B outsourcing facilities, and pharmaceutical companies across North America (and selectively South America). The company's core service is radiation-based terminal sterilization using beta and photon radiation to achieve a sterility assurance level of 10⁻⁶, with a 2-business-day turnaround that the company positions against the 5-8 business day standard for gamma sterilization. Underlying capacity is provided through an exclusive partnership with Steri-Tek, which operates the accelerator infrastructure.

MediZap packages its offering as a "Four Pillar Service": (1) E-Beam/X-Ray sterilization, (2) proprietary packaging solutions (Medi-Packs single-use primary packaging, Steri-Packs multi-use secondary packaging, Disperse-Packs single-use secondary packaging, plus 2:1 and 3:1 custom labels with integrated irradiation indicators), (3) compliance support covering FDA, USP (<797>, <800>), DEA, SPB, and ISO frameworks, and (4) exclusive partnerships with Pacific BioLabs (ISO testing/validation), Element Materials Technology (analytical chemistry and sterility testing), Complete Group Services (a GSO for compounding), and kadara medical (trocar devices). The pre-validated packaging and dosimetry profile function as a switching-cost mechanism.

The business model combines usage-based sterilization fees, hardware/physical product sales (packaging and labels), and professional services (compliance and consulting). Pricing is quote-based and not publicly disclosed. MediZap is a California LLC (Medizap LLC), co-founded and controlled by Jonathan Bergstrom (CEO) and Nicole Bergstrom (COO), with no disclosed institutional investors or parent company. The company operates from Loomis, California, with 11-50 employees, and runs a content-driven marketing program (webinars, newsletter, blog) to build category authority in the compounding pharmaceutical sterilization niche.

Short descriptiontext

MediZap is a private U.S. service provider that delivers E-Beam and X-Ray terminal sterilization, proprietary packaging, and compliance support to 503A compounding pharmacies, 503B outsourcing facilities, and pharmaceutical companies across North America through exclusive partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNational City, United States
HQ citystring
National City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
terminal sterilization services, E-beam sterilization, X-ray irradiation, compounding pharmacy services, sterile pharmaceutical packaging
Industry3 codes
PRIMARYHLAHANAB
Sterilization Services & Contract Reprocessing (ETO/Gamma/E-beam providers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
SECONDARYHLAHANAC
Sterilization Consumables & Packaging (Wraps, Pouches, Indicators, Trays/Containers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
SECONDARYIMALAIAB
Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers)
NAICS code1 code
  • Medical Equipment and Supplies Manufacturing3391
Product category
Pharmaceutical Sterilization Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Terminal Sterilization Services
TypeUsage Based
Description

E-Beam and X-Ray terminal sterilization services for compounded pharmaceuticals, offering fastest turnaround times (2 business days vs. 5-8 days for Gamma), dedicated capacity, and highest sterility assurance level of 10⁻⁶.

medizap.co
2Packaging Solutions
TypeHardware Sales
Description

Primary and secondary packaging solutions including Medi-Packs (single-use), Steri-Packs (multi-use), and Disperse-Packs (single-use secondary packaging), along with custom labeling solutions using NiceLabel software and Cab Squix printers.

medizap.co
3Compliance Services
TypeProfessional Services
Description

Document control, regulatory audit preparation support, and compliance advisement for FDA, USP, SPB, and DEA requirements.

medizap.co
4Exclusive Partnership Services
TypeManaged Services
Description

Integrated services through exclusive partnerships including validation services, sterile compounding testing, and consulting support.

medizap.co
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1STERI-PACK INNOVATIONS
Description

MediZap's research and development team created next generation secondary packaging for 30ml, 50ml & 100ml vial solutions.

medizap.co
+3 more records
Core offering1 text field

MediZap delivers E-Beam and X-Ray terminal sterilization services for compounded pharmaceuticals at partner Steri-Tek's ISO 13485/ISO 11137 accredited facilities, achieving a 10⁻⁶ sterility assurance level with a 2-business-day turnaround. Its Four Pillar Service bundles that sterilization with pre-validated primary and secondary packaging (Medi-Packs, Steri-Packs, Disperse-Packs), custom labeling, FDA/USP/DEA/SPB compliance support, and exclusive CRO/GSO partnerships for 503A compounding pharmacies, 503B outsourcing facilities, and pharmaceutical manufacturers across North and South America.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 2 business day turnaround vs. 5-8 business days for Gamma sterilization
+2 more records
Product overview1 text field

MediZap offers a unified Four Pillar Service platform for compounded pharmaceutical sterilization. The core service is E-Beam | X-Ray terminal sterilization, which integrates with proprietary packaging solutions (Medi-Packs, Steri-Packs, Disperse-Packs) and labeling solutions (2:1 and 3:1 Labels). Supporting modules include cold chain logistics and compliance support. The company positions itself as North America's premier turn-key service provider for electron beam and X-ray sterilization serving compounding pharmacies and pharmaceutical manufacturers across North America.

Product and service5 records
1E-Beam | X-Ray Sterilization
CategoryTerminal Sterilization Services
Description

Advanced electron beam and X-ray terminal sterilization services for compounded pharmaceuticals, delivered through partner Steri-Tek's ISO 13485 and ISO 11137 accredited facility with 10⁻⁶ sterility assurance and a 2-business-day turnaround versus 5–8 business days for Gamma sterilization. Built for sterile drug manufacturers and designed as a Compounding Center of Excellence with dedicated capacity and no reservation requirements.

2Medi-Packs
CategoryPrimary Packaging
Description

Single-use primary packaging for validated drug products, including blister packs, vials, and caps, validated specifically for Electron-Beam processing with built-in color irradiation indicators. Bundled and unitized for easy ordering.

3Steri-Packs
CategorySecondary Packaging
Description

Multi-use secondary packaging solutions for terminal sterilization via E-Beam/X-Ray technology, protecting products with custom multi-layer high-density foam. Available in Standard (2ml–10ml vials), Tall (30ml–100ml vials), and Cold variants. Includes MediZap Steri-Pack Innovations next-generation secondary packaging for 30ml, 50ml, and 100ml vial solutions.

4Disperse-Packs
CategorySecondary Packaging
Description

Single-use secondary packaging for the transfer of product from sterilization packaging to fulfillment-ready solutions, accommodating various vial sizes and ophthalmic droppers.

5Compliance Support
CategoryRegulatory Compliance Services
Description

Document control, regulatory audit preparation, and compliance advisement for compounding pharmacies and pharmaceutical manufacturers against ISO 11137 + 11737, IOH, FDA, USP, SPB, and DEA requirements. Includes guidance on USP <797>, USP <800>, and cGMP compliance delivered through a multi-layered quality control team.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeTechnology or Integration
Description

MediZap is an exclusive partner to SteriTek for all terminal sterilization with dedicated capacity for customers. SteriTek operates the most advanced accelerators for high and low volume E-Beam | X-Ray terminal sterilization. The facility is accredited to ISO 13485 and ISO 11137, with DEA licenses for controlled substances. The partnership provides full process validated sterilized drug product without costly setup and processing fees.

Strategic tierCoreTypeTechnology or Integration
Description

Pacific BioLabs is a contract research organization (CRO) exclusively partnered with MediZap for ISO testing and validations supporting new product sterilization validations and ongoing process validations. Specializing in biological sciences with cGMP and GLP compliance and ISO 17025 accreditation. Located in San Francisco Bay Area for close support to Steri-Tek.

Strategic tierCoreTypeTechnology or Integration
Description

Exclusive partnership integrating Element's sterile compounding testing services, analytical chemistry, environmental monitoring, and USP <797>, USP <800>, and cGMP FDA compliance expertise into MediZap's Four Pillar Service. Services include peel off sample submission, Q-Alerts quality investigations, and advanced testing technologies including Rapid Sterility USP <1223> BacT | ALERT®.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Complete Group Services is the first and only GSO created for compounding and manufacturing of pharmaceutical products. Partnership adds benefits including Marketing and Consulting Support, Vendor Contracts, and Consolidated Points of Contact. Free membership for 503A compounding pharmacies and 503B outsourcing facilities through MediZap.

5kadara™ medical
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

kadara™ medical sets the gold standard for FDA registered American manufacturer of pellet therapy trocar devices and trocar kits. Utilizes the same E-beam sterilization technology from MediZap's exclusive partner SteriTek. Offers exclusive pricing and customer support to MediZap customers for medical practitioners.

medizap.co
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Steri-Tek operates E-Beam and X-Ray contract sterilization facilities and is MediZap's exclusive capacity partner. It is directly comparable as a provider of high-energy terminal sterilization services for pharma and medical devices, and is the most natural direct competitor should it choose to sell directly to compounders.

TypeBroad incumbent
Description

Sterigenics is the largest global contract sterilization provider, predominantly Gamma and EtO, serving pharma, medical device, and food customers. It is the incumbent benchmark MediZap references (5–8 day Gamma turnaround) and represents the most significant competitive force in terminal sterilization.

3STERIS
TypeBroad incumbent
Description

STERIS is a global leader in sterilization and infection prevention products and contract sterilization services. It competes broadly across sterilization modalities and serves many of the same pharma and medical-device customers MediZap targets.

TypeDirect peer
Description

E-BEAM Services operates contract electron-beam sterilization facilities in the U.S. for medical devices and pharmaceutical products. It is a direct E-Beam peer using the same underlying technology modality that MediZap packages into its compounding-pharma offering.

TypeEmerging player
Description

Noxilizer provides nitrogen dioxide terminal sterilization services aimed at pharma, biotech and medical devices. It competes in the same 'alternatives to Gamma' lane as MediZap and targets customers seeking faster, lower-temperature sterilization options.

TypeBroad incumbent
Description

Cantel provides contract sterilization and infection-prevention services for medical devices and life-science products. Comparable as a multi-modality sterilization services vendor serving healthcare-adjacent manufacturers.

TypeBroad incumbent
Description

Getinge offers sterilization equipment and contract sterilization services across pharma and healthcare. It is comparable as a large incumbent with multi-modality sterilization capabilities serving sterile manufacturing customers.

TypeEmerging player
Description

Bioquell specializes in bio-decontamination using hydrogen peroxide vapor for pharma compounding and cleanroom environments. It overlaps with MediZap in serving 503A/503B contamination-control needs, particularly around USP <797>/<800> compliance.

TypeRegional player
Description

Fagron is a leading supplier of pharmaceutical raw materials, equipment and services to compounding pharmacies globally. It is comparable because MediZap's customers are Fagron's buyers; both compete for share of the 503A/503B wallet.

10PCCA (Professional Compounding Centers of America)
TypeRegional player
Description

PCCA supports compounding pharmacies with APIs, equipment, training, and base formulations across North America. It targets the same 503A customer base MediZap addresses and is referenced in MediZap's industry-conference outreach.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MediZap

Pharmaceutical Sterilization Servicesmedizap.co

MediZap is a private U.S. service provider that delivers E-Beam and X-Ray terminal sterilization, proprietary packaging, and compliance support to 503A compounding pharmacies, 503B outsourcing facilities, and pharmaceutical companies across North America through exclusive partnerships.

What MediZap does

MediZap is a private U.S. service provider that delivers E-Beam (electron beam) and X-Ray terminal sterilization for compounded pharmaceuticals, targeting 503A compounding pharmacies, 503B outsourcing facilities, and pharmaceutical companies across North America (and selectively South America). The company's core service is radiation-based terminal sterilization using beta and photon radiation to achieve a sterility assurance level of 10⁻⁶, with a 2-business-day turnaround that the company positions against the 5-8 business day standard for gamma sterilization. Underlying capacity is provided through an exclusive partnership with Steri-Tek, which operates the accelerator infrastructure.

MediZap packages its offering as a "Four Pillar Service": (1) E-Beam/X-Ray sterilization, (2) proprietary packaging solutions (Medi-Packs single-use primary packaging, Steri-Packs multi-use secondary packaging, Disperse-Packs single-use secondary packaging, plus 2:1 and 3:1 custom labels with integrated irradiation indicators), (3) compliance support covering FDA, USP (<797>, <800>), DEA, SPB, and ISO frameworks, and (4) exclusive partnerships with Pacific BioLabs (ISO testing/validation), Element Materials Technology (analytical chemistry and sterility testing), Complete Group Services (a GSO for compounding), and kadara medical (trocar devices). The pre-validated packaging and dosimetry profile function as a switching-cost mechanism.

The business model combines usage-based sterilization fees, hardware/physical product sales (packaging and labels), and professional services (compliance and consulting). Pricing is quote-based and not publicly disclosed. MediZap is a California LLC (Medizap LLC), co-founded and controlled by Jonathan Bergstrom (CEO) and Nicole Bergstrom (COO), with no disclosed institutional investors or parent company. The company operates from Loomis, California, with 11-50 employees, and runs a content-driven marketing program (webinars, newsletter, blog) to build category authority in the compounding pharmaceutical sterilization niche.

MediZap firmographics

Firmographics
Name
MediZap
Legal name
Medizap LLC
Website
https://medizap.co
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
MediZap is a private U.S. service provider that delivers E-Beam and X-Ray terminal sterilization, proprietary packaging, and compliance support to 503A compounding pharmacies, 503B outsourcing facilities, and pharmaceutical companies across North America through exclusive partnerships.
Ownership category
akta.pro rank

MediZap industry classification

Industry
Product category
Pharmaceutical Sterilization Services
NAICS
Medical Equipment and Supplies Manufacturing (3391)
akta.pro industry
PRIMARYHLAHANAB
Sterilization Services & Contract Reprocessing (ETO/Gamma/E-beam providers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
SECONDARYHLAHANAC
Sterilization Consumables & Packaging (Wraps, Pouches, Indicators, Trays/Containers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
SECONDARYIMALAIAB
Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers)

Keywords

  • Terminal sterilization services
  • E-beam sterilization
  • X-ray irradiation
  • Compounding pharmacy services
  • Sterile pharmaceutical packaging

Where MediZap is headquartered

Location

Headquarters

HQ city
National City
HQ country
United States
HQ region
North America

Offices1 record

Markets served

MediZap business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Terminal Sterilization Services: E-Beam and X-Ray terminal sterilization services for compounded pharmaceuticals, offering fastest turnaround times (2 business days vs. 5-8 days for Gamma), dedicated capacity, and highest sterility assurance level of 10⁻⁶.
  2. Packaging Solutions: Primary and secondary packaging solutions including Medi-Packs (single-use), Steri-Packs (multi-use), and Disperse-Packs (single-use secondary packaging), along with custom labeling solutions using NiceLabel software and Cab Squix printers.
  3. Compliance Services: Document control, regulatory audit preparation support, and compliance advisement for FDA, USP, SPB, and DEA requirements.
  4. Exclusive Partnership Services: Integrated services through exclusive partnerships including validation services, sterile compounding testing, and consulting support.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

MediZap product offering

Product offering

Core offering

MediZap delivers E-Beam and X-Ray terminal sterilization services for compounded pharmaceuticals at partner Steri-Tek's ISO 13485/ISO 11137 accredited facilities, achieving a 10⁻⁶ sterility assurance level with a 2-business-day turnaround. Its Four Pillar Service bundles that sterilization with pre-validated primary and secondary packaging (Medi-Packs, Steri-Packs, Disperse-Packs), custom labeling, FDA/USP/DEA/SPB compliance support, and exclusive CRO/GSO partnerships for 503A compounding pharmacies, 503B outsourcing facilities, and pharmaceutical manufacturers across North and South America.

Product overview

MediZap offers a unified Four Pillar Service platform for compounded pharmaceutical sterilization. The core service is E-Beam | X-Ray terminal sterilization, which integrates with proprietary packaging solutions (Medi-Packs, Steri-Packs, Disperse-Packs) and labeling solutions (2:1 and 3:1 Labels). Supporting modules include cold chain logistics and compliance support. The company positions itself as North America's premier turn-key service provider for electron beam and X-ray sterilization serving compounding pharmacies and pharmaceutical manufacturers across North America.

Differentiator

Problem solved

Functional benefit

Brands

  • STERI-PACK INNOVATIONS: MediZap's research and development team created next generation secondary packaging for 30ml, 50ml & 100ml vial solutions.
  • MEDI-PACKS
  • STERI-PACKS
  • DISPERSE-PACKS

Products and services

  • E-Beam | X-Ray Sterilization Advanced electron beam and X-ray terminal sterilization services for compounded pharmaceuticals, delivered through partner Steri-Tek's ISO 13485 and ISO 11137 accredited facility with 10⁻⁶ sterility assurance and a 2-business-day turnaround versus 5–8 business days for Gamma sterilization. Built for sterile drug manufacturers and designed as a Compounding Center of Excellence with dedicated capacity and no reservation requirements.
  • Medi-Packs Single-use primary packaging for validated drug products, including blister packs, vials, and caps, validated specifically for Electron-Beam processing with built-in color irradiation indicators. Bundled and unitized for easy ordering.
  • Steri-Packs Multi-use secondary packaging solutions for terminal sterilization via E-Beam/X-Ray technology, protecting products with custom multi-layer high-density foam. Available in Standard (2ml–10ml vials), Tall (30ml–100ml vials), and Cold variants. Includes MediZap Steri-Pack Innovations next-generation secondary packaging for 30ml, 50ml, and 100ml vial solutions.
  • Disperse-Packs Single-use secondary packaging for the transfer of product from sterilization packaging to fulfillment-ready solutions, accommodating various vial sizes and ophthalmic droppers.
  • Compliance Support Document control, regulatory audit preparation, and compliance advisement for compounding pharmacies and pharmaceutical manufacturers against ISO 11137 + 11737, IOH, FDA, USP, SPB, and DEA requirements. Includes guidance on USP <797>, USP <800>, and cGMP compliance delivered through a multi-layered quality control team.

Quantifiable outcome

  • 2 business day turnaround vs. 5-8 business days for Gamma sterilization
  • +2 more outcomes

Companies that use MediZap

Customer profile

Segments3 records

Ideal customer profiles3 records

MediZap technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature4 records

MediZap partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and strategic.

  • Steri-TekcoreTechnology or IntegrationMediZap is an exclusive partner to SteriTek for all terminal sterilization with dedicated capacity for customers. SteriTek operates the most advanced accelerators for high and low volume E-Beam | X-Ray terminal sterilization. The facility is accredited to ISO 13485 and ISO 11137, with DEA licenses for controlled substances. The partnership provides full process validated sterilized drug product without costly setup and processing fees.
  • Pacific BioLabscoreTechnology or IntegrationPacific BioLabs is a contract research organization (CRO) exclusively partnered with MediZap for ISO testing and validations supporting new product sterilization validations and ongoing process validations. Specializing in biological sciences with cGMP and GLP compliance and ISO 17025 accreditation. Located in San Francisco Bay Area for close support to Steri-Tek.
  • Element Materials Technology (Element)coreTechnology or IntegrationExclusive partnership integrating Element's sterile compounding testing services, analytical chemistry, environmental monitoring, and USP <797>, USP <800>, and cGMP FDA compliance expertise into MediZap's Four Pillar Service. Services include peel off sample submission, Q-Alerts quality investigations, and advanced testing technologies including Rapid Sterility USP <1223> BacT | ALERT®.
  • Complete Group Services (CGS)coreStrategic or Co-development PartnerComplete Group Services is the first and only GSO created for compounding and manufacturing of pharmaceutical products. Partnership adds benefits including Marketing and Consulting Support, Vendor Contracts, and Consolidated Points of Contact. Free membership for 503A compounding pharmacies and 503B outsourcing facilities through MediZap.
  • kadara™ medicalstrategicStrategic or Co-development Partnerkadara™ medical sets the gold standard for FDA registered American manufacturer of pellet therapy trocar devices and trocar kits. Utilizes the same E-beam sterilization technology from MediZap's exclusive partner SteriTek. Offers exclusive pricing and customer support to MediZap customers for medical practitioners.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

MediZap competitors and assessment

Company assessment

Direct peers

  • Steri-Tek: Steri-Tek operates E-Beam and X-Ray contract sterilization facilities and is MediZap's exclusive capacity partner. It is directly comparable as a provider of high-energy terminal sterilization services for pharma and medical devices, and is the most natural direct competitor should it choose to sell directly to compounders.
  • E-BEAM Services: E-BEAM Services operates contract electron-beam sterilization facilities in the U.S. for medical devices and pharmaceutical products. It is a direct E-Beam peer using the same underlying technology modality that MediZap packages into its compounding-pharma offering.

Broad incumbents

  • Sterigenics (Sotera Health): Sterigenics is the largest global contract sterilization provider, predominantly Gamma and EtO, serving pharma, medical device, and food customers. It is the incumbent benchmark MediZap references (5–8 day Gamma turnaround) and represents the most significant competitive force in terminal sterilization.
  • STERIS: STERIS is a global leader in sterilization and infection prevention products and contract sterilization services. It competes broadly across sterilization modalities and serves many of the same pharma and medical-device customers MediZap targets.
  • Cantel Medical (now part of STERIS): Cantel provides contract sterilization and infection-prevention services for medical devices and life-science products. Comparable as a multi-modality sterilization services vendor serving healthcare-adjacent manufacturers.
  • Getinge: Getinge offers sterilization equipment and contract sterilization services across pharma and healthcare. It is comparable as a large incumbent with multi-modality sterilization capabilities serving sterile manufacturing customers.

Emerging players

  • Noxilizer: Noxilizer provides nitrogen dioxide terminal sterilization services aimed at pharma, biotech and medical devices. It competes in the same 'alternatives to Gamma' lane as MediZap and targets customers seeking faster, lower-temperature sterilization options.
  • Bioquell (Ecolab): Bioquell specializes in bio-decontamination using hydrogen peroxide vapor for pharma compounding and cleanroom environments. It overlaps with MediZap in serving 503A/503B contamination-control needs, particularly around USP <797>/<800> compliance.

Regional players

  • Fagron: Fagron is a leading supplier of pharmaceutical raw materials, equipment and services to compounding pharmacies globally. It is comparable because MediZap's customers are Fagron's buyers; both compete for share of the 503A/503B wallet.
  • PCCA (Professional Compounding Centers of America): PCCA supports compounding pharmacies with APIs, equipment, training, and base formulations across North America. It targets the same 503A customer base MediZap addresses and is referenced in MediZap's industry-conference outreach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

MediZap social profiles

Digital presence

MediZap compliance and trust

Trust signal

Compliance5 records

MediZap financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MediZap leadership team

Management profile

Number of profiles

Profiles4 records

MediZap funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MediZap M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MediZap

What does MediZap do?

MediZap delivers E-Beam and X-Ray terminal sterilization services for compounded pharmaceuticals at partner Steri-Tek's ISO 13485/ISO 11137 accredited facilities, achieving a 10⁻⁶ sterility assurance level with a 2-business-day turnaround. Its Four Pillar Service bundles that sterilization with pre-validated primary and secondary packaging (Medi-Packs, Steri-Packs, Disperse-Packs), custom labeling, FDA/USP/DEA/SPB compliance support, and exclusive CRO/GSO partnerships for 503A compounding pharmacies, 503B outsourcing facilities, and pharmaceutical manufacturers across North and South America.

Is MediZap a public or private company?

MediZap is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was MediZap founded?

MediZap was founded in 2018. It employs 1 to 10 people.

Where is MediZap based?

MediZap is headquartered in National City, United States, in the North America region.

How does MediZap make money?

Four revenue lines are on record. Terminal Sterilization Services are the primary driver. The others are packaging Solutions, compliance Services and exclusive Partnership Services.

Who are MediZap's main competitors?

Direct peers on record are Steri-Tek and E-BEAM Services. Broad incumbents are Sterigenics (Sotera Health), STERIS, Cantel Medical (now part of STERIS) and Getinge. Emerging players are Noxilizer and Bioquell (Ecolab). Regional players are Fagron and PCCA (Professional Compounding Centers of America).

Does MediZap have an API?

No public API is recorded for MediZap.

What industry is MediZap in?

MediZap's product category is Pharmaceutical Sterilization Services. Its primary akta.pro industry code is HLAHANAB, Sterilization Services & Contract Reprocessing (ETO/Gamma/E-beam providers), with a secondary code of HLAHANAC, Sterilization Consumables & Packaging (Wraps, Pouches, Indicators, Trays/Containers). Its NAICS code is 3391.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals